FDA: No reports of illness due to recalled infant formula products 

The Food and Drug Administration (FDA) said on Monday that it has yet to receive reports of illness or adverse effects due to the intake of the recently recalled infant formula products. 

FDA said it is overseeing and validating the voluntary recall by Nestlé Philippines on some batches of its two infant formula products as a precautionary measure following a potential safety and quality concern involving an ingredient. 

“The voluntary recall follows a reported incident involving a raw material from the manufacturer’s supplier. At present, there are no established food safety or regulatory limits on the raw material identified,” the agency said in a statement. “The FDA is conducting an ongoing investigation to determine the scope of the issue and to assess any potential safety implications.”

“At this time, the FDA has not received any reports of illness or adverse events associated with the recalled products. While no adverse events have been reported, the FDA fully supports this precautionary action to protect public health, especially infants and young children,” it added.

Nestlé Philippines earlier assured that only a small number of batches in the Philippines are affected. Consumers can check if the item they bought is affected by the recall by inputting the batch number found on the box and foil packaging in this website: https://www.parenteam.com.ph/voluntary-precautionary-recall

Further, the FDA advises consumers to immediately discontinue the use of the affected products and strictly follow the recall instructions by the manufacturer. 

“The FDA will continue to carry out post-market surveillance, inspections, and product assessments to ensure that all regulated products in the market meet established safety and quality requirements. Any significant findings will be promptly disclosed in the interest of transparency and consumer protection,” the agency said.—LDF, GMA Integrated News